No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis

ConclusionsThe anti-Rank ligand and PTH analogs have no impact on cardiovascular risk and overall mortality in idiopathic osteoporosis. To better answer the question whether these treatments can reduce the long-term cardiovascular risk, further comparative studies with longer duration are required.

http://link.springer.com/10.1007/s11657-019-0672-4

Source: Archives of Orthopaedic and Trauma Surgery - January 2, 2020 Category: Orthopaedics Source Type: research